Earlier this week 13 pharmaceutical companies*, together with several government and nongovernmental organizations**, pledged to find solutions to eliminate or control 10 neglected tropical diseases (NTDs) by the year 2020. At an event in London, pharmaceutical companies committed to invest in research and development (R&D) to find new treatments for NTDs along with increasing donations of existing drugs.

Op-ed co-authored by Dr. Peter Hotez appears in The Atlantic

January 19, 2012 | The Atlantic

A Military Cutback We Can't Afford: Fighting Tropical Diseases

By Peter Hotez and James Kazura

Jan 19 2012, 8:06 AM ET

As long as we have a military presence in areas known for infectious diseases, we have to keep researchers working on improved treatments.

The Atlantic
In an op-ed published Friday, Sabin president Peter Hotez, M.D., Ph.D., and his Baylor College of Medicine colleague, William Brinkley, Ph.D., applaud the dramatic gains Texas institutions have made to become leaders among the global scientific community. They cite the routinely high ranking of public and private Texas universities as well as a voter approved amendment to start the Cancer Prevention and Research Institute of Texas (CPRIT).

Merck Serono plans to double its donation from 25 million tablets to 50 million tablets and will continue a commitment to donations indefinitely, until schistosomiasis has been eliminated in Africa.

NTD control is also important for success in fighting other important diseases – notably HIV/AIDs, tuberculosis and malaria.  In Africa, there are high rates of co-infection among NTDs and HIV/AIDs, tuberculosis and malaria, demonstrating an increased need for more research to unlock the links b

Exclusive interview with Dr. Neeraj Mistry, managing director for the Global Network for Neglected Tropical Diseases

November 15, 2011 | Africa News Analysis (ANA)

By Musah Ibrahim Musah

“Addressing NTDs improves productivity and contribute to broader economic growth and prosperity of countries”

- says Dr Neeraj Mistry, Managing Director, Global Network for Neglected Tropical Diseases in an exclusive interview with ANA’s Musah Ibrahim Musah in Berlin, Germany.

Excerpts follow:

African News Analysis

Second article in VOA NTD news series: Billion people suffer from neglected tropical diseases

November 8, 2011 | Voice of America

By Vidushi Sinha

A billion people around the world suffer from neglected tropical diseases, and the global health community is working to develop new drugs, vaccines and diagnostics. But experts note that success is uneven in part because of different rules and regulations in different countries for drug development and testing.

...

Dr. Peter Hotez, president of Sabin Vaccine Institute, says it is much easier to test new therapies in India than in other parts of the world.

Voice of America

Dr. Peter Hotez featured in a video interview with Voice of America

November 3, 2011

Neglected Diseases Afflict S. Asia's Poor
By Vidushi Sinha

At a time when economists predict that South Asia's economy will grow, health experts point to hundreds of millions suffering from neglected infections, often as a result of poverty. In a series of new studies, researchers say many countries in South Asia bear a disproportionate burden of these diseases and have a need for new drugs and vaccines.

Voice of America

Pages